A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial
Titel:
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial
Auteur:
Dodewaard-de Jong, Joyce M. van Klerk, John M. H. de Bloemendal, Haiko J. Oprea-Lager, Daniela E. Hoekstra, Otto S. Berg, H. Pieter van den Los, Maartje Beeker, Aart Jonker, Marianne A. O’Sullivan, Joe M. Verheul, Henk M. W. Eertwegh, Alfons J. M. van den
Verschenen in:
European journal of nuclear medicine and molecular imaging